For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Monoclonal is a class of antibodies, which are derived from the identical offspring of a hybridomas. These antibodies can be grown indefinitely and are very specific for a particular location in the body derived from a single clone. Monoclonal antibodies recognize and bind to antigens to discriminate between specific epitopes, which provides protection against disease organisms. The specificity of MABs allow its binding to cancerous cells, which then seek outs to destroy the cancer cells. Monoclonal antibody custom service offers the selection of the developed rat and mouse hybridomas for the production of custom monoclonal antibodies from synthesized peptide or recombinant protein antigens. These services provides a comprehensive services for antibody cloning, expression, engineering, and purification in addition to custom antibody development for multiple pharmaceutical and biotechnological companies.
The Monoclonal Antibody Custom Service market revenue was 1161.86 Million USD in 2022, and will reach 1659.37 Million USD in 2028, with a CAGR of 6.12% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Monoclonal Antibody Custom Service industry, and breaks down according to the type, application, and consumption area of Monoclonal Antibody Custom Service. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Monoclonal Antibody Custom Service in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Monoclonal Antibody Custom Service market covered in Chapter 11:
Abcam
Thermo Fisher Scientific
Abnova Corporation
Creative-Biolabs
GenScript
In Chapter 3, on the basis of types, the Monoclonal Antibody Custom Service market from 2018 to 2028 is primarily split into:
Rat Custom Monoclonal Antibody
Rabbit Custom Monoclonal Antibody
Others.
In Chapter 4, on the basis of applications, the Monoclonal Antibody Custom Service market from 2018 to 2028 covers:
Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028